Number of Participants With First Event of Ischemic/Unspecified Stroke, Hemorrhagic Stroke, or Systemic Embolism (SE) During the Intended Treatment Period [clinicaltrials_resource:NCT00412984/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Participants With First Event of Ischemic/Unspecified Stroke, Hemorrhagic Stroke, or Systemic Embolism (SE) During the Intended Treatment Period [clinicaltrials_resource:NCT00412984/outcome/1]
Bio2RDF identifier
NCT00412984/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00412984/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Intention to treat analysis, r ...... cy cut-off date (30-Jan-2011).
Intention to treat analysis, r ...... cy cut-off date (30-Jan-2011).
Intention to treat analysis, r ...... nts experiencing stated event.
Intention to treat analysis, r ...... cy cut-off date (30-Jan-2011).
Intention to treat analysis, r ...... stated combination of events.
Treated participants. Particip ...... ticipants experiencing events.
Treated participants. Particip ...... w-up) at the end of the study.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
"Intended Treatment Period" st ...... an-2011, prior to unblinding).
"Treatment Period" started wit ...... years in each treatment group.
Time to first event in "Intend ...... an-2011, prior to unblinding).
type [clinicaltrials_vocabulary:type]
Other Pre-specified
alternate
Number of Participants With Fi ...... the Intended Treatment Period
@en
identifier
clinicaltrials_resource:NCT00412984/outcome/1
title
All suspected efficacy events ...... g, or other objective testing.
@en
type
label
Number of Participants With Fi ...... esource:NCT00412984/outcome/1]
@en